01366nam a2200289Ia 4500001001200000003000800012006001900020007001500039008004100054010001700095020001500112040002100127035002000148050002700168082001700195110010400212245027100316260005500587300002900642504004100671533015200712650001500864650002500879655002900904710001700933856012600950ebr10055149CaPaEBRm        u        cr cn|||||||||980107s1997    dcua    sb    000 0 eng d  z   98119250   z0309059763  aCaPaEBRcCaPaEBR  a(OCoLC)4347734414aRM666.T784bI56 1997eb04a615/.7822212 aInstitute of Medicine (U.S.).bCommittee on Halcion: An Assessment of Data Adequacy and Confidence.10aHalcionh[electronic resource] :ban independent assessment of safety and efficacy data /cCommittee on Halcion: An Assessment of Data Adequacy and Confidence, Division of Health Sciences Policy, Division of Neuroscience and Behavioral Health, Institute of Medicine.  aWashington, D.C. :bNational Academy Press,c1997.  axviii, 158 p. :btables.  aIncludes bibliographical references.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2009.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aTriazolam. 0aTranquilizing drugs. 7aElectronic books.2local2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10055149zAn electronic book accessible through the World Wide Web; click to view